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Abstract
Background: The purpose of this study was to undertake an independent investigation into the effects of
ingesting a carbohydrate-protein-electrolyte (CPE) beverage on repeated submaximal and time-trial cycling
performance.
Methods: Sixteen recreationally trained males (height: 1.76 ± 0.07 m; weight: 70.05 ± 7.90 kg; VO2max: 49.69 ± 4.19
ml.kg-1.min-1) performed two exercise trials separated by 7 days. Each trial comprised two bouts of 90 minutes
exercise separated by a 2 hour recovery period. Each bout comprised 45 minutes exercise on a cycle-ergometer at
60%VO2max (ST), followed immediately by a 45 minute performance test (PT). Participants were randomly assigned
an 8% CPE beverage or colour/taste matched placebo (PL) prior to each trial. Participants consumed 100 ml of the
assigned beverage every 10 minutes during each ST, and 500 ml at 0 and 60 minutes into recovery (total caloric
delivery per trial: 617.6 kcal for CPE and12.8 kcal for PL). Mean power output (W), speed (km.hr-1) and distance
covered (km) were assessed throughout both trials. Expired air was sampled at 10 minute intervals throughout ST.
Blood glucose and lactate were assessed during ST and recovery.
Results: Distance covered during ST was significantly reduced with PL by 9.12% (20.18 ± 0.28 km in ST1 v 18.34 ±
0.36 km in ST2; P = 0.0001). With CPE, distance covered, power output and average speed were maintained
between ST1 and ST2. Oxygen uptake was not significantly different between ST1 and ST2, or conditions.
Respiratory exchange ratio (RER) values decreased from 0.98 ± 0.02 in ST1 to 0.91 ± 0.02 in ST2 for PL (P = 0.003),
supporting reduced total carbohydrate oxidation rates (P = 0.007). Mean blood glucose was maintained in CPE
across ST trials, and was significantly greater than PL in ST2 (4.77 ± 0.09 mmol.L-1 for CPE compared with 4.18 ±
0.06 mmol.L-1 for PL, P < 0.001). Mean distance during PT2 was 2.96 km (or 17.1%) further with CPE than PL (P =
0.003). Mean power significantly decreased across PT with PL (134.21 ± 4.79 W and 106.90 ± 3.25 W, respectively; P
< 0.04).
Conclusions: The use of a CPE beverage improves short-term repeated exercise and subsequent performance
compared to PL. Higher rates of carbohydrate oxidation, maintenance of plasma glucose, and decreased levels of
fatigue may be beneficial for secondary bouts of performance and faster recovery turnover.
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Background
The introduction of the Nutrition and Health Claims
Regulation in 2006 has provided focused guidelines
across the European Union for the use of nutrition/
health claims, for example “the maintenance of endur-
ance performance” for specific nutrition products. This
Regulation aims to ensure that any claim made on
foods’ labelling, presentation or marketing in the Eur-
opean Union is clear, accurate and based on evidence
accepted by the scientific community. Consequently
foods or products bearing claims that could mislead
consumers may well be eliminated from the market.
As a result, there is increasing interest for sports
nutrition product manufacturers to undertake specific
research to validate or support marketing claims.
VIPER®ACTIVE is a specific sports drink produced by
Maxinutrition Ltd. The product is a carbohydrate-pro-
tein-electrolyte (CPE) formula designed to support exer-
cise performance, energy production, stamina and short
term recovery from intense training. The manufacturer
guidelines indicate a dosage of 40 g of the product
(mixed with 500 ml of water) for use during exercise
bouts, equating to an 8.0% concentration (or 7.1% for
total carbohydrate).
It is widely established that the ingestion of carbohy-
drate (CHO) during exercise can improve time to
exhaustion [1], through maintenance of plasma glucose
concentrations, and increasing total carbohydrate oxida-
tion (CHOTOT) rates [2]. Additional evidence exists that
by increasing exogenous carbohydrate oxidation
(CHOEXO) rates [3], beverages containing multiple CHO
combinations may have further ergogenic potential [4].
The inclusion of essential electrolytes, namely sodium,
into such beverages has also been shown to enhance or
support higher hydration levels, or ingestion rates, dur-
ing and post exercise [5-7].
There has been recent interest in the use of carbohy-
drate-protein (CP) combinations as a means to not only
enhance time to exhaustion compared to a CHO bever-
age [8], but also to improve post exercise recovery rates.
It has been demonstrated [9] that the ingestion of a car-
bohydrate-casein hydrolysate beverage significantly
enhanced late stage cycling time trial performance in
comparison to CHO only; and attenuated post exercise
creatine kinase concentrations along with subjective
muscle soreness. The ergogenic potential of CP bev-
erages firstly appears to be explained by the high CHO
ingestion rates of ~60 g.hr-1, along with an independent
caloric advantage though the co-ingestion of ~20 g.hr-1
of protein. The innovation of nutrient timing has also
implied the need for early carbohydrate [10] and/or pro-
tein ingestion post exercise [11], particularly when
repeated short term training bouts are undertaken.
Practical methods to support initial training bouts, as
well as short term recovery are therefore warranted,
including the assessment of specific formulas which uti-
lise a complete array of essential nutrients, namely com-
bined carbohydrates, essential amino acids and key
electrolytes, that may enhance acute and repeated bouts
of exercise.
The aim of this study was therefore to undertake an
independent assessment of the potential influence of a
commercially available CPE beverage (VIPER®ACTIVE)
on repeated submaximal physiological and work output
parameters in comparison to a matched placebo (PL). A
further aim was to assess the influence of both bev-
erages on subsequent time trial performance following
short term recovery.
Methods
Participants
Seventeen healthy males volunteered for participation in
the study. Participants were required to be 18-40 years
of age, and to be recreationally active. For study inclu-
sion, participants were required to: satisfactorily com-
plete a health screen questionnaire; not be taking any
other supplementation; not have dysglycemia or known
diabetic conditions; and have a maximal oxygen uptake
between 40-59 ml·kg-1∙min-1. Following a study briefing,
all participants provided written, informed consent for
inclusion. Ethical approval for the study was provided
by the University of Hertfordshire Life Sciences Ethics
Committee.
Preliminary testing
All testing was undertaken in the Human Physiology
Laboratory, Division of Sport, Health and Exercise, Uni-
versity of Hertfordshire. Upon entry to the laboratory,
nude body mass (Seca 780, Hamburg, Germany) and
height were recorded. All participants then performed a
maximal oxygen uptake (VO2max) test on a Computrai-
ner cycle-ergometer (RaceMate Inc., Seattle, US) to
assess against inclusion criteria. After a 5 minute warm-
up at a standardised 100 W workload, a continuous
ramp protocol (starting at 150 W) was employed with
workload increasing at a rate of 15 W.min-1.
Expired air was sampled throughout all tests with an
online gas analyser (Metalyser 3B, Cortex Biophysik,
Leipzig, Germany) to assess VO2max and other respira-
tory variables. Heart rate (HR) was measured by means
of a telemetric system (Polar Electro Oy, Kempele, Fin-
land). Ratings of perceived exertion (RPE) were collected
at 1 minute intervals, using the Borg 6-20 subjective
exertion scale [12]. The test concluded when partici-
pants reached volitional exhaustion or were unable to
maintain the required power output.
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VO2max was defined when a minimum of two of the
following criteria were attained: 1) an increase of no
more than 2 ml·kg-1·min-1 in oxygen consumption with
additional workload, 2) attainment of maximal predicted
heart rate (± 10 beats.min-1) and 3) a respiratory
exchange ratio (RER) of > 1.05. Maximal power (Wmax)
was calculated by adding the fraction of time spent in
the final non-completed workload, multiplied by the 15
W increment, to the final completed workload.
Only one participant did not fulfil the inclusion cri-
teria, and was therefore withdrawn from the experimen-
tal study. Remaining participants undertook an
habituation trial a week later to confirm the exercise
intensity required for the main experiment using the
same cycle-ergometer. Participant data are shown in
Table 1.
Experimental trials
Experimental trials were conducted under laboratory
and temperature controlled conditions (temperature:
20.2 ± 0.5°C; barometric pressure - range: 904-1015
mBar; and relative humidity -range: 24-47%), with no
statistically significant differences demonstrated between
trials (P > 0.05) for any of the environmental variables.
A randomised, double-blind, placebo controlled design
was employed, with participants being required to
attend the laboratory at the same time of day over two
trials (separated by one week). Participants were
requested to arrive at the laboratory having overnight
fasted (12 hours) and having refrained from strenuous
activity for the previous 72 hours. Additionally, indivi-
dual food diaries for the 72 hours prior to each trial
were provided by all subjects to assess for dietary com-
pliance. On arrival to the laboratory, participants were
required to complete a subjective muscle soreness ques-
tionnaire for the knee extensors and hamstring areas, as
well as a daily analysis of life demands for athletes ques-
tionnaire (DALDA [13]).
Each trial consisted of two exercise bouts separated by
a two hour recovery period. For each exercise bout, par-
ticipants were required to complete a 45 minute sub-
maximal exercise period (ST), followed immediately by
a 45 minute time trial performance test (PT). A standar-
dised warm up of 5 minutes at 100 W on the same
Computrainer cycle-ergometer used in pre-testing con-
ditions was employed for all participants prior to each
exercise bout. At the end of the warm up period, parti-
cipants were provided with an opaque drinks bottle
containing 500 ml of either the test drink (40 g of a
combined dextrose, maltodextrin and hydrolysed whey
protein formula (VIPER®ACTIVE, Maxinutrition Ltd.)
delivering an 8% concentrated solution) or a taste/
appearance matched citrus fruit concentrate placebo. A
fixed volume of 100 ml was consumed by the partici-
pants at 0, 10, 20, 30 and 40 minutes of the submaximal
exercise period. The test beverage per 100 g comprised:
7.1 g of protein; 88.4 g of total carbohydrate (of which
50.6 g glucose); 0.4 g of total fat; 0.53 g of sodium; 0.03
g of magnesium; 0.17 g of potassium and 0.14 g of cal-
cium, and delivered 386 kcal. Conversely the placebo
beverage per 100 g comprised: 0.6 g of total carbohy-
drate; 0.2 g of protein; trace amounts of total fat and
sodium, and delivered only 8 kcal.
Submaximal exercise (ST1) comprised 45 minutes
cycling at a workload equivalent to 60% VO2max. During
the ST period, capilliarised fingertip blood sampling
(100 μl) was undertaken at 10 minute intervals for the
assessment of blood lactate and glucose (Biosen C, EKF
Diagnostics, Barleben, Germany). Respiratory measure-
ments were ascertained at 10 minute intervals during
ST to confirm intensity adherence utilising expired air
analysis. RPE and HR measurements were collected at 5
minute intervals. Mean power output (W), speed (km.
hr-1) and distance covered (km) were also assessed dur-
ing ST.
On completion of the ST protocol, participants imme-
diately undertook a 45 minute maximal time trial per-
formance test (PT1). Only time elapsed was visible to
the participants. No test drinks were administered dur-
ing PT1. Mean power output (W), speed (km.hr-1), dis-
tance covered (km), RPE and HR were assessed at 10
minute intervals during PT1.
At the end of the first 90 minute exercise period, par-
ticipants undertook a 2 hour superivsed recovery period.
During this period participants were provided with 500
ml of the test drink at 0 and 60 minutes into recovery.
In addition, all participants received a standard protein
meal bar (Promax™ Meal Bar, Maxinutrition Ltd.) at 60
minutes into recovery. This was to avoid any unneces-
sary risks of severe hypoglycaemia occurring during the
placebo trial. The standard protein bar comprised 206
kcal, containing 21.6 g of protein, 17.0 g of carbohydrate
(of which 9.5 g sugars), 5.7 g of total fat, and 0.05 g of
sodium.
At the end of the recovery period, all participants
underwent a second exercise period, comprising the
Table 1 Summary of participant characteristics and pre-experimental data collection
Age (Years) Height (m) Weight (kg) VO2max (L.min
-1) VO2max (ml.kg
-1.min-1) Wmax (watts)
19.56 ± 0.89 1.76 ± 0.07 70.05 ± 7.90 3.47 ± 0.49 49.69 ± 4.19 267.38 ± 30.75
Values are presented as mean ± SD; n = 16; VO2max, maximal oxygen uptake; Wmax, maximal power output.
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same protocol for both submaximal (ST2) and time trial
performance (PT2) previously described. Participants
returned to the laboratory one week later to complete
the same experimental procedure on the alternate drink.
On completion of each trial, participants were provided
with three muscle soreness/DALDA questionnaires for
completion on waking on days 1, 2, and 3.
Calculations and statistical analyses
Calculation of total carbohydrate (CHOTOT) and fat oxi-
dation (FATTOT) rates in g.min
-1 were assessed using
absolute expired air measurements of VO2 and VCO2
(L.min-1) according to the following stoichiometric
equations [14]:
CHOTOT = 4.585 · VCO2 − 3.226 · VO2
FATTOT = 1.695 · VO2 − 1.701 · VCO2
Statistical analyses were performed using SPSS Statis-
tics for Windows version 17 (SPSS, Chicago, USA). A
two-way analysis of variance (ANOVA) for repeated
measures was used to assess interactions between trial
(ST or PT), condition (beverage used) and where applic-
able, time, for all variables. Where F ratios were found
to be significant a Bonferroni post hoc test was applied.
An alpha level of 0.05 was employed for assessment of
statistical significance. All data are reported as means ±
SE.
Results
Submaximal exercise trials (ST)
Distance, speed and power output
Data for distance covered (km) and average speed out-
put (km.hr-1) are represented in Table 2. There was a
significant interaction effect for total distance covered
during submaximal exercise (F = 8.054; P = 0.013).
Whereas total distance covered with CPE was not differ-
ent between trials; there was a significant reduction in
mean distance covered with PL (20.18 ± 0.28 km in ST1
v 18.34 ± 0.36 km in ST2; P = 0.0001). This represented
a 9.12% decrease in submaximal performance with PL.
In addition, reduced distance covered in ST2 for the PL
condition was specifically noted in the last 15 minutes
of the trial (P = 0.0001). Accordingly, there was a similar
interaction effect for average speed output during sub-
maximal exercise between trials and conditions (F =
8.724; P = 0.010).
Data for average power output are shown in Figures 1
and 2. During submaximal exercise, there was a signifi-
cant interaction effect for average power output (F =
7.637; P = 0.015). Over the full 45 minute trial, power
output significantly decreased by 10.9% from 128.89 ±
3.61 W in ST1 to 114.82 ± 4.04 W in ST2 (P = 0.002)
for PL only. A similar pattern was observed for the last
15 minutes of the exercise trial, with average power out-
put being significantly lower in ST2 (112.38 ± 4.22 W)
compared to ST1 (128.38 ± 3.85 W) for PL only (P =
0.0001). No significant differences were found for the
CPE beverage between trials.
Cardio-respiratory and subjective exertion data
Data for submaximal cardiorespiratory variables, total
oxidation rates and RPE data are represented in Table 3.
No significant differences were found within condition or
between trials for oxygen consumption (VO2) (P > 0.05),
demonstrating adherence to the exercise intensity. There
was, however, a significant difference between trials for
carbon dioxide (VCO2) production (F = 18.814; P =
0.001). VCO2 was significantly lower in ST2 compared to
ST1 for PL (1.816 ± 0.076 L.min-1 v 2.031 ± 0.100 L.min-
1, P = 0.0001). There was also a significant difference in
mean VCO2 in ST2 between PL and CPE (1.816 ± 0.076
L.min-1 v 1.914 ± 0.066 L.min-1 respectively, P = 0.029).
A significant interaction effect was found for CHOTOT
across trials (F = 22.407; P = 0.0001). With PL, mean
CHOTOT significantly reduced from 2.729 ± 0.328 g.min
-1
in ST1 to 1.891 ± 0.226 g.min-1 in ST2 (P = 0.007). Whilst
mean CHOTOT reduced between submaximal bouts, no
significant differences were observed between trials with
CPE. Similarly, a significant interaction effect was found
for FATTOT across trials (F = 21.330; P = 0.0001). Mean
FATTOT increased across submaximal exercise bouts, but
was only deemed significant with PL (increasing from
0.004 ± 0.108 g.min-1 in ST1 to 0.293 ± 0.085 g.min-1 in
ST2; P = 0.036).
Table 2 Comparison between test beverages on distance covered and average speed during submaximal exercise
trials
PL CPE
ST 1 ST 2 ST 1 ST 2
Total Distance Covered (km) 20.18 ± 0.28 18.34 ± 0.36* 20.03 ± 0.32 19.17 ± 0.44
Distance in last 15 mins(km) 6.65 ± 0.11 5.84 ± 0.16* 6.67 ± 0.12 6.32 ± 0.18
Average Speed (km.hr-1) 26.89 ± 0.39 24.67 ± 0.46* 26.54 ± 0.36 25.70 ± 0.56
Average Speed - last 15 mins (km.hr-1) 27.05 ± 0.39 24.75 ± 0.49* 26.72 ± 0.43 25.64 ± 0.58
Values are presented as mean ± SE; n = 16; PL, Placebo; CPE, carbohydrate-protein-electrolyte; ST1, submaximal exercise trial 1, ST2, submaximal exercise trial 2. *
denotes significant difference (P = 0.0001) between trials within condition only.
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There was a significant interaction effect found for
average heart rate data (F = 25.756; P = 0.0001). Despite
similar trends between conditions, average heart rate
(b.min-1) was only significantly elevated in the PL group
between trials (P = 0.02). No significant differences were
reported for RPE data within condition or between
trials.
Wholeblood data
Data for blood glucose are represented in Figure 3. No
significant differences were found between trials or con-
ditions for resting values (P = 0.327). There was, how-
ever, a significant interaction effect over both time and
condition (F = 3.654; P = 0.01). Mean blood glucose was
significantly greater over the first exercise bout with
CPE compared to PL (5.06 ± 0.13 mmol.L-1 and 4.53 ±
0.08 mmol.L-1 respectively; P = 0.002).
During recovery between exercise bouts, there was a
significant interaction effect (P < 0.001), with mean
blood glucose being significantly lower with PL both at
30 minutes (6.30 ± 0.30 mmol.L-1 for CPE and 3.87 ±
0.12 mmol.L-1 for PL, P < 0.01) and 60 minutes (5.47 ±
0.27 mmol.L-1 for CPE and 3.82 ± 0.12 mmol.L-1 for PL,
P < 0.01). Mean blood glucose in ST2 was maintained
with CPE compared to ST1; and was significantly higher
than with PL during ST2 (4.77 ± 0.08 mmol.L1 for CPE
compared with 4.18 ± 0.06 mmol.L-1 for PL, P < 0.001).
Data for blood lactate are represented in Figure 4.
Whilst there were no significant differences for resting
lactate between conditions, blood lactate was elevated at
the beginning of the second exercise bout with CPE
compared to the first bout only (1.74 ± 0.21 mmol.L-1
compared to 1.04 ± 0.12 mmol.L-1, P = 0.04). Mean
data demonstrated a significant decrease in blood lactate
between exercise bouts for CPE (2.47 ± 0.20 mmol.L-1
compared to 1.78 ± 0.18 mmol.L-1, P = 0.005) and for
PL (2.75 ± 0.26 mmol.L-1 compared to 1.67 ± 0.17
mmol.L-1, P = 0.009). There were no other significant
differences reported between conditions.
Time trial performance data
Data for overall distance covered during the time trial
performance tests (PT) are shown in Figure 5. A signifi-
cant interaction effect was found for total distance cov-
ered (F = 12.231; P = 0.004). No differences were
reported between conditions for PT1. However, with PL,
average distance covered fell from 21.64 ± 0.58 km in
PT1 to 17.27 ± 0.62 km in PT2 (P = 0.0001), represent-
ing a 20.2% reduction in performance. Total distance
covered was also lower in PT2 compared to PT1 with
CPE (20.23 ± 0.65 km v 22.55 ± 0.34 km respectively; P
= 0.02), representing a 10.3% reduction in performance.
However, there was a significant difference between
conditions following PT2, with the CPE group cycling
on average 2.96 km further than the PL group (P =
0.003) representing a 17.1% difference between
conditions.
Additionally, assessment of distance covered in the
last 15 minutes of the PT revealed a significant interac-
tion effect (F = 6.288; P = 0.024), with mean distance
reducing from 7.29 ± 0.21 km to 5.81 ± 0.24 km with
PL across trials (P = 0.0001), and from 7.76 ± 0.15 km
to 6.74 ± 0.25 km with CPE across trials (P = 0.007).
The reduction observed with PL was 16.0% greater than
with CPE for PT2 (P = 0.01).
Data for average speed (km.hr-1) and power output
(W) during the PT tests are shown in Table 4 including
Figure 2 Assessment of test beverages on average power
output (watts) during final 15 minutes of submaximal exercise
trials. Data is presented as mean ± SE; n = 16. PL, Placebo; CPE,
carbohydrate-protein-electrolyte; ST1, submaximal exercise trial 1,
ST2, submaximal exercise trial 2. * denotes significant difference
P = 0.0001) between trials within condition only.
Figure 1 Assessment of test beverages on average power
output (watts) during submaximal exercise trials. Data is
presented as mean ± SE; n = 16. PL, Placebo; CPE, carbohydrate-
protein-electrolyte; ST1, submaximal exercise trial 1, ST2, submaximal
exercise trial 2. * denotes significant difference P = 0.002) between
trials within condition only.
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data for mean heart rate (b.min-1) and RPE. A signifi-
cant interaction effect was found for average speed (F =
13.486; P = 0.003). Whilst data was not different
between conditions for PT1, average speed was reduced
in PT2 for both conditions (P < 0.04). Furthermore,
average speed in PT2 was significantly greater by 8.86%
with CPE compared to PL (P = 0.02). Data was also sig-
nificantly different over the last 15 minutes of PT2, with
average speed being greater by 10.2% with CPE com-
pared to PL (P = 0.009). Accordingly, a similar interac-
tion effect was reported for power output (F = 9.660; P
= 0.008), particularly with regards to a significantly
lower average power output reported between PT trials
for PL (P = 0.0001). At the end of PT2, average power
output was 15.9% higher with CPE compared to PL (P =
0.008), and 18.8% higher when data for the last 15 min-
utes was assessed (P = 0.004).
A significant interaction effect was found for heart
rate data across trials (F = 17.220; P = 0.001), with
average heart rate shown to be significantly lower in
PT2 compared to PT1 for PL only (P = 0.005). No other
differences were observed for heart rate between trials
or conditions. Data for RPE demonstrated consistent
hard to very hard exertion across PT tests, and was sig-
nificantly higher in PT2 compared to PT1 only (F =
4.752; P = 0.047). No other differences were observed
for RPE within or between conditions.
Post trial questionnaire and subjective muscle soreness
assessment
The DALDA questionnaire is divided into two sections
representing factors associated with life stress (part A)
and symptoms of stress (part B). No significant differ-
ences were found for any of the pre trial DALDA
responses (P > 0.05). Data for post trial responses are
shown in Table 5. No significant interaction effect was
Figure 4 Assessment of test beverages on blood lactate
mmol.L-1) during submaximal exercise trials. Data is presented
as mean ± SE; n = 16. PL, Placebo; CPE, carbohydrate-protein-
electrolyte; ST1, submaximal exercise trial 1, ST2, submaximal
exercise trial 2. * denotes significant difference P < 0.05) between
trials within condition only PL). b denotes significant difference
P < 0.05) between trials within condition only CPE).
Table 3 Comparison between test beverages on cardiorespiratory variables, total oxidation rates and subjective
exertion data during submaximal exercise trials
PL CPE
ST 1 ST 2 ST 1 ST 2
VO2 (L.min
-1) 2.040 ± 0.058 1.995 ± 0.071 2.062 ± 0.058 2.052 ± 0.071
VCO2 (L.min
-1) 2.031 ± 0.100 1.816 ± 0.076* 2.021 ± 0.064 1.914 ± 0.066#
RER 0.98 ± 0.02 0.91 ± 0.02* 0.98 ± 0.02 0.94 ± 0.01
CHOTOT (g.min
-1) 2.729 ± 0.328 1.891 ± 0.226* 2.615 ± 0.216 2.159 ± 0.132
FATTOT (g.min
-1) 0.004 ± 0.108 0.293 ± 0.085* 0.057 ± 0.083 0.221 ± 0.049
VE (L.min
-1) 51.74 ± 2.60 50.39 ± 2.94 47.94 ± 2.16 47.62 ± 2.36**
Heart Rate (b.min-1) 136.88 ± 2.73 142.58 ± 3.03* 138.83 ± 2.77 145.39 ± 2.54
RPE (6-20) 11.21 ± 0.43 12.39 ± 0.60 11.46 ± 0.43 11.99 ± 0.52
Values are presented as mean ± SE; n = 16; PL, Placebo; CPE, carbohydrate-protein-electrolyte; ST1, submaximal exercise trial 1, ST2, submaximal exercise trial 2;
VO2, oxygen consumption; VCO2, expired carbon dioxide; RER, respiratory exchange ratio; CHOTOT, total carbohydrate oxidation; FATTOT, total fat oxidation; VE,
minute ventilation; RPE, rating of perceived exertion. * denotes significant difference (P < 0.05) between trials within condition only. # denotes significant
difference (P < 0.05) from PL within trial. ** denotes significant difference between conditions overall (P < 0.05).
Figure 3 Assessment of test beverages on blood glucose
(mmol.L-1) during submaximal exercise trials. Data is presented
as mean ± SE; n = 16. PL, Placebo; CPE, carbohydrate-protein-
electrolyte; ST1, submaximal exercise trial 1, ST2, submaximal
exercise trial 2. * denotes significant difference P < 0.005) between
trials within condition only. # denotes significant difference
P < 0.008) between conditions within trial.
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found for life stress responses across days or conditions
(P > 0.05). For part B, whilst a significant interaction
effect was demonstrated across days (F = 4.708;
P = 0.021), post hoc analysis only revealed a trend for
lower overall responses on day 3 compared to day 1
(P = 0.08).
No significant differences were found for any of the
pre trial muscle soreness assessments (P > 0.05). Post
trial muscle soreness assessment data are represented
in Table 5. Mean quadriceps soreness was significantly
different post trial (F = 7.824; P = 0.013), with soreness
ratios only different between days 1 and 3 (P = 0.05).
Data was not different between conditions (P > 0.05).
Likewise, mean vastus lateralis (VL), and mean distal
VL soreness assessment was significantly different
between days 1 and 2, and 1 and 3 post trial only (P <
0.05). No other differences were observed for soreness
data.
Discussion
Submaximal exercise
One of the key findings from this study was that the
ingestion of a CPE beverage maintained total distance,
average speed and power output in ST2 when compared
to PL. At a prescribed exercise intensity, total distance
covered significantly decreased by 9.12% from 20.18 ±
0.28 km in ST1 to 18.34 ± 0.36 km in ST2 when partici-
pants consumed a fruit concentrate PL. In contrast,
there was no significant difference between ST1 and
ST2 for total distance covered when participants con-
sumed a CPE beverage. Whilst there were no differences
found between conditions for ST1 or ST2, the signifi-
cant reduction in work output for the PL group does
support previous research indicating that CHO ingestion
is likely to be more beneficial for longer duration [15,16]
or subsequent high intensity exercise bouts [17].
Additionally, as there has been previous interest in the
effect of CHO beverages in the latter stages of exercise,
the decrement in exercise maintenance with the inges-
tion of PL was also observed in the last 15 minutes of
ST2. When participants undertook ST2 during the PL
condition, average speed significantly reduced from
27.05 ± 0.39 km.hr-1 in ST1 to 24.75 ± 0.49 km.hr-1 in
ST2. This was replicated with a significant reduction in
average power output in the final 15 minutes of ST2 of
16.0 W in the PL condition. As the degree of statistical
significance was greater at 45 minutes compared with
30 minutes, it can be inferred that the level of fatigue
was exacerbated in the last 15 minutes without ingestion
of CPE.
The maintenance of submaximal work output
observed with CPE indicates the beneficial effects of
such beverages on single day repeated training sessions.
It is probable that such replication of work output is
explained by the maintenance of plasma glucose, espe-
cially in ST2. Interestingly, the ingestion of CPE resulted
in a greater mean blood glucose in the first exercise
bout compared with PL (5.06 ± 0.13 mmol.L-1 and
Table 4 Comparison between test beverages on average speed, power, heart rate and RPE data during a 45 minute
cycling performance trial
PL CPE
PT 1 PT 2 PT 1 PT 2
Average speed (km.hr-1) 27.52 ± 0.47 23.93 ± 0.45* 27.64 ± 0.41 26.05 ± 0.58*#
Average speed (last 15 mins: km.hr-1) 27.73 ± 0.50 23.71 ± 0.47* 28.06 ± 0.42 26.14 ± 0.60*#
Average power (W) 134.21 ± 4.79 106.90 ± 3.25* 136.82 ± 3.80 123.97 ± 4.42#
Average power (last 15 mins: W) 136.70 ± 5.21 105.30 ± 3.18* 141.52 ± 3.99 125.14 ± 4.69#
Heart Rate (b.min-1) 155.53 ± 4.27 140.34 ± 4.54* 163.84 ± 3.60 153.73 ± 4.45
RPE (6-20) 15.75 ± 0.46 16.45 ± 0.41 15.87 ± 0.45 16.35 ± 0.46b
Values are presented as mean ± SE; n = 16; PL, Placebo; CPE, carbohydrate-protein-electrolyte; PT1, performance time trial 1, PT2, performance time trial 2; RPE,
rating of perceived exertion. * denotes a significant difference from PT1 within condition (P < 0.04), # denotes a significant difference between conditions within
trial (P < 0.02), b denotes a significant difference between trials only (P < 0.05).
Figure 5 Assessment of test beverages on total distance
covered km) during a 45 minute cycling performance test. Data
is presented as mean ± SE; n = 16. PL, Placebo; CPE, carbohydrate-
protein-electrolyte; PT1, performance time trial 1, PT2, performance
time trial 2. * denotes significant difference P < 0.05) between trials
within condition only.# denotes significant difference from PL within
trial P = 0.003).
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4.53 ± 0.08 mmol.L-1 respectively), but this did not
impact on short term work output in ST1. The mainte-
nance of a higher mean blood glucose was further
apparent with CPE in ST2 (4.77 ± 0.08 mmol.L-1 com-
pared with 4.18 ± 0.06 mmol.L-1 for PL), which poten-
tially contributed to overall and end stage work output.
The ingestion of a PL beverage clearly resulted in
increased levels of fatigue, demonstrated by significant
reductions in power output and total distance covered
during ST2 relative to ST1. Concomitant reductions in
VCO2, RER and CHOTOT suggest that depletion of
endogenous energy stores may be the major mechanism
contributing to short term fatigue, particularly in a gly-
cogen-fasted state. With increased utilisation of endo-
genous carbohydrate, there will be a decreased reliance
on glycolytic flux and hence reduced lactic acid produc-
tion, as demonstrated in the PL condition. With a
reduced demand to buffer hydrogen ion production, this
likely explains the significantly lowered VCO2 levels
observed in ST2 for PL. Whilst mean CHOTOT was
observed to decrease in ST2 with CPE (from 2.615 ±
0.216 g.min-1 in ST1 to 2.159 ± 0.132 g.min-1 in ST1),
the reduction was not significant, and indicates a rela-
tive maintenance of CHOTOT throughout the repeated
submaximal exercise. The absolute reduction between
submaximal bouts for CHOTOT in the CPE trial could
be explained by low carbohydrate ingestion rates used
in the study.
Whilst CHOTOT was not assessed during the recovery
period, the inclusion of a double bolus of the test bever-
age at 0 and 60 minutes of recovery resulted in signifi-
cant differences in mean blood glucose between
conditions at 30 minutes (6.30 ± 0.30 mmol.L-1 for CPE
and 3.87 ± 0.12 mmol.L-1 for PL) and 60 minutes (5.47
± 0.27 mmol.L-1 for CPE and 3.82 ± 0.12 mmol.L-1 for
PL) of the recovery period. The inclusion of a standard
protein bar at 60 minutes into the recovery period was
employed to minimise any absolute risk of hypoglycae-
mia in the PL condition, and to replicate strategies often
employed by athletes in daily practice. In the CPE
condition a total of 123.1 g of CHO was therefore
ingested prior to the start of ST2 in comparison to 17.7
g ingested with the PL condition. Prior to the start of
ST2, this would have equated to a total CHO ingestion
rate of 0.59 g.min-1 for the CPE condition. This is con-
siderably below the 1.0-1.2 g.min-1 suggested saturation
range of intestinal glucose transporters [16,18], yet still
infers an ergogenic benefit.
Performance exercise
There has been much, and often controversial interest,
in the potential performance ergogenic effects of CHO
beverages both for shorter duration exercise sessions, as
well as repeated bouts. It is widely known that in the
absence of sufficient CHO, absolute work output will
gradually decline with exercise duration and intensity,
based on both liver and muscle glycogen depletion rates,
and associated mechanisms of intracellular fatigue. In
this study, the use of a CPE beverage did not confer
performance advantages in PT1 compared to PL, with
average power outputs being comparable (134.21 ± 4.79
W for PL and 136.82 ± 3.80 W for CPE). Interestingly,
in PT1, mean distance when consuming CPE was 0.91
km greater than PL, which comprised a 4.2% overall
improvement comparable to other studies [19].
The lack of statistical significance between conditions
for PT1 however do conflict with other studies both for
cycling [20] and running tests [21]. In the latter study,
the ingestion of a 6.4% CHO-E solution 30 minutes
before and at 15 minute intervals during a 1-hr treadmill
run, significantly improved performance by 2.7%. Both
studies proposed that the inclusion of carbohydrate prior
to exercise resulted in higher CHOTOT which conveyed
the performance increments in the latter stages of exer-
cise. In the current study, carbohydrate ingestion pre-
ceded PT1, but not under resting conditions. The lack of
difference in CHOTOT between conditions for ST1 sug-
gests that ingestion rates were not of sufficient magni-
tude to elicit short term performance gains. In the
previous study [21], participants ingested a total of 67.1 g
Table 5 Assessment of test beverage influence on post trial DALDA questionnaire and subjective muscle soreness
PL CPE
P1 P2 P3 P1 P2 P3
DALDA Part A 1.46 ± 0.39 1.08 ± 0.33 0.85 ± 0.27 1.00 ± 0.30 1.15 ± 0.30 1.08 ± 0.24
DALDA Part B 3.08 ± 0.76 3.15 ± 0.94 1.92 ± 0.74 3.23 ± 0.65 2.15 ± 0.59 1.77 ± 0.30
MQS 2.21 ± 0.35 1.65 ± 0.20 1.49 ± 0.16 1.68 ± 0.21 1.36 ± 0.14 1.28 ± 0.15*
MVLS 2.27 ± 0.38 1.62 ± 0.21 1.50 ± 0.16 1.65 ± 0.22 1.35 ± 0.15 1.19 ± 0.13*#
MDVLS 2.31 ± 0.35 1.54 ± 0.18 1.46 ± 0.14 1.69 ± 0.26 1.31 ± 0.17 1.15 ± 0.10*#
MHS 2.15 ± 0.33 1.69 ± 0.21 1.35 ± 0.13 1.73 ± 0.31 1.58 ± 0.30 1.42 ± 0.21
Values are presented as mean ± SE; n = 16; PL, Placebo; CPE, carbohydrate-protein-electrolyte; P1-3, post trial days 1 to 3; MQS, mean quadriceps soreness; MVLS,
mean vastus lateralis soreness; MDVLS, mean distal vastus lateralis soreness; MHS, mean hamstring soreness.* denotes a significant reduction between P1 and P3
overall (P < 0.05). # denotes a significant reduction between P1 and P2 overall (P < 0.05).
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of CHO prior to completion of a time trial (effectively an
ingestion rate of 0.75 g.min-1). In the current study, parti-
cipants ingested a total of 35.4 g CHO prior to comple-
tion of PT1 (an effective ingestion rate of 0.39 g.min-1). It
is therefore possible that higher ingestion rates either pre
exercise and/or during PT1 may have resulted in signifi-
cant short term gains.
However, when repeated bouts of exercise are underta-
ken, the beneficial effects of CPE ingestion appear to be
more pronounced. Total distance covered in PT2 was
17.1% greater with the ingestion of CPE compared to PL.
The demanding nature of the trials was observed, with a
significant 10.3% reduction in total distance covered
between trials for the CPE condition (22.55 ± 0.34 km for
PT1 compared to 20.23 ± 0.65 km in PT2), potentially
explained by the relatively low total CHO ingestion rates
employed.
Average power output during (and in the final 15
minutes) of PT2 were significantly reduced in PL,
demonstrating the contrasting benefits of CPE. Whilst
the type and quantity of CHO has been shown to
enhance exogenous CHO oxidation rates [3,7,18], late
stage performance enhancement may still occur with
more conservative ingestion rates. By the start of PT2,
during the CPE trial, participants had consumed a total
of 158.5 g CHO or 37.3 g.hr-1. Comparable ingestion
rates have been shown to enhance late stage exercise
performance elsewhere [22] despite being below known
optimal delivery rates of 1-1.2 g.min-1 or 60-70 g.hr-1
[16].
It is most likely that any ergogenic or recovery effects
from the CPE beverage are explained by the combination
of the maltodextrin and dextrose formulation. It has been
demonstrated that the inclusion of multiple carbohy-
drates will result in higher exogenous carbohydrate oxi-
dation (CHOEXO) rates [23]. The combined uptake of
total sugars from the sodium dependent glucose trans-
porter (SGLT1) and GLUT5 intestinal transport mechan-
isms provides potential for maximal exogenous oxidation
rates [3]. Whilst the oxidation rates of both dextrose and
maltodextrin are similar, the inclusion of maltodextrin
reduces beverage osmolarity, hence increasing the poten-
tial for carbohydrate delivery to the intestinal lumen, as
well as fluid uptake.
Furthermore, the inclusion of sodium to the test bev-
erage is known to enhance carbohydrate bioavailability
[24]. Despite relatively low CHO ingestion rates
employed in the current study, an enhancement in both
CHO delivery and CHOEXO would still have a resultant
sparing or even suppressing effect on endogenous CHO
utilisation [25], as well as maintaining the CHOTOT
observed between performance bouts. As CHOEXO rates
have typically been shown to plateau after 90 minutes of
steady state exercise, this in part explains the ergogenic
potential observed in PT2 with CPE.
Alternatively, as CHO ingestion rates were below opti-
mal delivery levels, it is possible that the co-ingestion of
protein may have provided additional ergogenic value
through increased caloric content. Whilst it has been
suggested the addition of approximately 2% protein to a
CHO beverage has minimal effect on subsequent perfor-
mance, or glycogen resynthesis [26,27], other studies
have demonstrated a positive effect of co-ingestion of
protein on endurance performance [8,9,28,29] and short
term recovery [30]. When carbohydrate-protein bev-
erages have been administered during acute recovery (in
comparison to an iso-energetic carbohydrate beverage),
there is supporting evidence that the addition of protein
positively enhances repeated same day time to exhaus-
tion trials [31,32]. The most likely explanation for this is
the higher caloric content of the beverages employed, in
comparison to lower dose carbohydrate only beverages
[32]. In the current study, as the protein intake for CPE
was only 0.6% or 2.84 g per 40 g serve, any enhance-
ment of acute recovery through insulin-mediated path-
ways would most likely be explained via the inclusion of
a standard protein bar between exercise trials.
In terms of short term recovery post trials, the only
significant observations from this study were reductions
in mean quadriceps soreness, mean vastus lateralis sore-
ness and mean distal vastus lateralis soreness by day 3.
This was expected considering subjects had a 7 day rest
period between trials, hence explaining the gradual
reduction in perceived soreness for both conditions. As
no differences were found between conditions for post
exercise muscle soreness or DALDA responses, the
inclusion of early protein feeding (mainly in the form of
a protein meal bar) may have assisted recovery in both
conditions, as demonstrated elsewhere [33]. It has been
suggested that the inclusion of protein to a carbohydrate
beverage during early recovery, particularly in higher
dosages than the present study, may facilitate intracellu-
lar rps6 and mTor signalling pathways leading to
enhanced protein resynthesis and hence recovery
[34-36]. However, beneficial effects of such beverages on
acute glycogen resynthesis is most likely accounted for
by underlying carbohydrate dosage and content [37].
Conclusions
In conclusion, the ingestion of commercially available
CPE beverage, significantly impacted on both repeated
submaximal exercise and cycling time trial performance
in comparison to PL. Through maintenance of blood
glucose concentrations and CHOTOT, the potential spar-
ing of endogenous energy stores supports the inclusion
of a CPE beverage for ergogenic benefits. Such bev-
erages may be particularly relevant where recovery
Roberts et al. Journal of the International Society of Sports Nutrition 2012, 9:5
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between bouts of exercise is relatively short and/or gly-
cogen depletion may significantly increase levels of
fatigue.
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